KLRS Kalaris Therapeutics, Inc.

Fundamentals / CIK 0001754068 / USD

Kalaris Therapeutics, Inc. reported $89.00M in total assets and a net loss of $43.40M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KLRS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$20.27M$10.14M$0-$178.1MFY 2019 Revenue: $165KFY 2019 Net Income: -$23.84M2019FY 2020 Net Income: -$69.78M2020FY 2021 Net Income: -$172.0M2021FY 2022 Net Income: -$168.7M2022FY 2023 Net Income: -$190.4M2023FY 2024 Net Income: -$69.17M2024FY 2025 Net Income: -$43.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- $165K
Research & Development $30.75M $45.04M $133.1M $118.9M $120.7M $49.66M $16.25M
Total Operating Expenses $46.15M $51.73M $199.9M $171.2M $169.8M $71.31M $26.87M
Operating Income -$46.15M -$51.73M -$199.9M -$171.2M -$169.8M -$71.31M -$26.70M
EBITDA -$46.14M -- -$199.5M -$170.5M -$169.6M -$71.24M -$26.68M
Interest Income -- $5.49M $5.73M $1.88M $1.31M $1.33M $2.06M
Interest Expense $1.44M $2.70M -- -- -- -- --
Income Before Tax -$43.44M -$69.17M -$190.5M -$169.0M -$171.0M -$69.78M -$23.84M
Income Tax Expense $0 $0 -$126K -$265K $1.01M -- --
Net Income -$43.44M -$69.17M -$190.4M -$168.7M -$172.0M -$69.78M -$23.84M
Basic EPS -$2.85 -$51.77 -$3,660.00 -$4,397.80 -$5,477.26 -$5,177.41 -$37,061.47
Diluted EPS -$2.85 -$51.77 -$3,660.00 -$4,397.80 -$5,477.26 -$5,177.41 -$37,061.47
Basic Shares Outstanding 15.3M 1.3M 52.0K 38.3K 31.4K 13.5K 643
Diluted Shares Outstanding 15.3M 1.3M 52.0K 38.3K 31.4K 13.5K 643

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $8.34M $9.02M $7.57M $7.16M $9.13M $8.44M $6.03M $3.85M
Total Operating Expenses $11.81M $12.39M $11.83M $10.80M $12.74M $12.26M $10.35M $7.13M
Operating Income -$11.81M -$12.39M -$11.83M -$10.80M -$12.74M -$12.26M -$10.35M -$7.13M
EBITDA -$11.80M -$12.38M -$11.82M -- -- -- -- --
Interest Income -- -- -- -- -- -- -- $1.39M
Interest Expense $0 $0 $0 $0 $0 $0 $1.44M $1.31M
Net Income -$11.03M -$11.52M -$10.86M -$10.00M -$11.89M -$11.35M -$10.20M -$22.03M
Basic EPS -$0.46 -$0.48 -$0.46 -- -$0.64 -$0.61 -$2.52 --
Diluted EPS -$0.46 -$0.48 -$0.46 -- -$0.64 -$0.61 -$2.52 --
Basic Shares Outstanding 23.8M 23.8M 23.7M -- 18.7M 18.7M 4.1M --
Diluted Shares Outstanding 23.8M 23.8M 23.7M -- 18.7M 18.7M 4.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $98.05M $1.64M $90.12M $106.1M $201.7M $122.7M $61.08M
Short-Term Investments $19.93M $0 $93.82M $127.7M $46.46M $233.7M $64.99M
Cash & Short-Term Investments $118.0M $118.3M $183.9M $233.8M $248.1M $356.3M $126.1M
Total Current Assets $118.8M $2.61M $187.6M $243.1M $253.3M $361.3M $127.3M
Property, Plant & Equipment, Net -- -- -- $930K $1.55M $812K $350K
Long-Term Investments $0 -- -- -- -- -- --
Other Non-Current Assets $953K $410K $122K $612K $1.10M -- --
Total Non-Current Assets $2.93M $3.56M $3.16M $34.03M $33.25M $9.50M $12.11M
Total Assets $121.7M $6.16M $190.8M $277.1M $286.6M $370.8M $139.4M
Accounts Payable $1.28M $1.56M $6.76M $3.00M $8.36M $963K $630K
Other Current Liabilities -- $22K $739K -- -- -- --
Total Current Liabilities $9.71M $24.70M $28.37M $24.34M $37.85M $12.29M $9.11M
Total Non-Current Liabilities $33.21M $32.08M $16.65M $28.22M $23.48M $5.46M $8.69M
Total Liabilities $42.92M $56.78M $45.02M $52.56M $61.33M $17.76M $17.80M
Total Debt (incl. Leases) $1.45M -- $27.43M $35.39M $30.07M $8.69M $11.76M
Common Stock $2.0K $0 $0 $9.0K $7.0K $7.0K --
Retained Earnings -$160.0M -$116.6M -$656.2M -$465.8M -$297.1M -$125.1M -$55.32M
Accumulated Other Comp. Income $6.0K $0 -$62K -$468K -$155K -$112K $68K
Total Stockholders' Equity $78.81M -$96.62M -$45.02M $224.5M $225.3M $353.1M -$51.50M
Total Equity $78.81M -$96.62M -$45.02M $224.5M $225.3M $353.1M -$51.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $47.38M $43.17M $34.43M $98.05M $42.39M $88.43M $101.0M $1.64M
Short-Term Investments $35.47M $50.37M $62.79M $19.93M $34.61M -- -- $0
Cash & Short-Term Investments $82.90M $93.50M $104.9M $118.0M $77K $88.43M $101.0M $118.3M
Total Current Assets $85.18M $95.92M $98.47M $118.8M $78.18M $91.65M $102.2M $2.61M
Long-Term Investments -- -- $7.65M $0 -- -- -- --
Other Non-Current Assets $1.98M $1.73M $1.75M $953K $976K $691K $410K $410K
Total Non-Current Assets $3.83M $3.62M $11.34M $2.93M $2.99M $1.19M $910K $3.56M
Total Assets $89.00M $99.54M $109.8M $121.7M $81.17M $92.84M $103.1M $6.16M
Accounts Payable $2.75M $1.12M $905K $1.28M $494K $3.68M $2.37M $1.56M
Other Current Liabilities -- -- -- -- -- -- $230K $22K
Total Current Liabilities $8.51M $8.74M $8.08M $9.71M $6.07M $7.65M $7.14M $24.70M
Total Non-Current Liabilities $33.09M $33.13M $33.17M $33.21M $33.24M $32.08M $32.08M $32.08M
Total Liabilities $41.60M $41.87M $41.25M $42.92M $39.31M $39.73M $39.22M $56.78M
Total Debt (incl. Leases) $1.33M $1.40M $1.41M $1.45M $1.54M -- -- --
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $0
Retained Earnings -$193.4M -$182.4M -$170.9M -$160.0M -$150.0M -$138.1M -$126.8M -$116.6M
Accumulated Other Comp. Income -$69K -$73K -$49K $6.0K $6.0K -- -- $0
Total Stockholders' Equity $47.40M $57.67M $68.56M $78.81M $41.87M $53.12M $63.87M -$96.62M
Total Equity $47.40M $57.67M $68.56M $78.81M $41.87M $53.12M $63.87M -$96.62M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$43.44M -$69.17M -$190.4M -$168.7M -$172.0M -$69.78M -$23.84M
Depreciation & Amortization $13K -- $398K $723K $189K $73K $19K
Stock-Based Compensation $1.94M $895K $40.78M $41.31M $43.98M $9.43M $2.89M
Change in Payables -$88K -$1.03M -- -- -- -- --
Operating Cash Flow -$38.37M -$20.67M -$124.5M -$142.1M -$106.3M -$60.81M -$20.16M
Capital Expenditure -$200K -- -- -- -$26K -$235K -$339K
Free Cash Flow -$38.57M -- -- -- -$106.3M -$61.05M -$20.49M
Purchases of Investments -$34.52M -- -$125.8M -$228.8M -$76.59M -$300.3M -$119.3M
Investing Cash Flow -$19.72M $95.00M $37.98M -$80.48M $186.0M -$169.5M -$64.64M
Common Stock Issued $42.00M -- -- $126.4M -- -- --
Financing Cash Flow $155.0M $19.14M $70.50M $127.0M $232K $292.0M $120.9M
Net Change in Cash $96.91M -$1.53M -$15.97M -$95.57M $79.85M $61.58M $36.12M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$11.03M -$11.52M -$10.86M -$10.00M -$11.89M -$11.35M -$10.20M -$22.03M
Depreciation & Amortization $10K $10K $10K -- -- -- -- --
Stock-Based Compensation $752K $644K $580K $333K $638K $591K $374K $280K
Change in Payables $1.71M $144K -$376K $874K -$3.20M $1.31M $934K -$898K
Operating Cash Flow -$10.55M -$11.05M -$11.58M -$7.06M -$11.33M -$12.54M -$7.44M -$7.85M
Purchases of Investments -$159K $169K -$70.35M -- -- -- -- --
Investing Cash Flow $14.84M $20.17M -$50.35M -- -- -- -- $5.00M
Financing Cash Flow -$75K -$377K -$1.70M $47.74M $0 $0 $107.3M $7.58M
Net Change in Cash $4.21M $8.75M -$63.63M $55.67M -$46.04M -$12.54M $99.83M -$274K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -- -16182.4%
Net Profit Margin -- -- -- -- -- -- -14447.9%
Return on Equity (ROE) -55.1% -- -- -75.1% -76.3% -19.8% --
Return on Assets (ROA) -35.7% -1122.5% -99.8% -60.9% -60.0% -18.8% -17.1%
Current Ratio 12.23x 0.11x 6.61x 9.99x 6.69x 29.39x 13.98x
Quick Ratio 12.15x 4.79x 6.48x 9.61x 6.55x 28.98x 13.85x
Debt to Equity 0.02x -- -- 0.16x 0.13x 0.02x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -91.5% -76.7% -64.3% -55.1% -132.5% -153.7% -118.9% --
Return on Assets (ROA) -48.8% -44.5% -40.2% -35.7% -68.3% -88.0% -73.7% -1122.5%
Current Ratio 10.00x 10.98x 12.19x 12.23x 12.89x 11.98x 14.31x 0.11x
Quick Ratio 9.74x 10.70x 12.98x 12.15x 0.01x 11.56x 14.14x 4.79x
Debt to Equity 0.03x 0.02x 0.02x 0.02x 0.04x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001754068) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal